These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11831929)

  • 1. Substance P, insulinlike growth factor 1, and surface healing.
    Lee CH; Whiteman AL; Murphy CJ; Barney NP; Taylor PB; Reid TW
    Arch Ophthalmol; 2002 Feb; 120(2):215-7. PubMed ID: 11831929
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1.
    Brown SM; Lamberts DW; Reid TW; Nishida T; Murphy CJ
    Arch Ophthalmol; 1997 Jul; 115(7):926-7. PubMed ID: 9230840
    [No Abstract]   [Full Text] [Related]  

  • 3. Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy.
    Nakamura M; Kawahara M; Nakata K; Nishida T
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2937-40. PubMed ID: 12824234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurrent corneal erosion with substance P-derived peptide and insulin-like growth factor I.
    Benitez-Del-Castillo JM; Rodríguez-Bayo S; Fontan-Rivas E; Martinez-de-la-Casa JM; Garcia-Sanchez J
    Arch Ophthalmol; 2005 Oct; 123(10):1445-7. PubMed ID: 16219742
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.
    Nagano T; Nakamura M; Nakata K; Yamaguchi T; Takase K; Okahara A; Ikuse T; Nishida T
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3810-5. PubMed ID: 12939296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I.
    Chikama T; Fukuda K; Morishige N; Nishida T
    Lancet; 1998 Jun; 351(9118):1783-4. PubMed ID: 9635953
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effect of topical SP, with or without IGF-1.
    Murphy CJ; Marfurt CF; McDermott A; Bentley E; Abrams GA; Reid TW; Campbell S
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2252-61. PubMed ID: 11527938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in treatment for neurotrophic keratopathy.
    Nishida T; Yanai R
    Curr Opin Ophthalmol; 2009 Jul; 20(4):276-81. PubMed ID: 19537364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational research in corneal epithelial wound healing.
    Nishida T
    Eye Contact Lens; 2010 Sep; 36(5):300-4. PubMed ID: 20724848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea.
    Nakamura M; Chikama T; Nishida T
    Br J Pharmacol; 1999 May; 127(2):489-97. PubMed ID: 10385250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential New Modes of Treatment of Neurotrophic Keratopathy.
    Yanai R; Nishida T; Chikama T; Morishige N; Yamada N; Sonoda KH
    Cornea; 2015 Nov; 34 Suppl 11():S121-7. PubMed ID: 26448169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance p and insulinlike growth factor I for neurotrophic keratitis.
    Brown SM; Khanani AM; Stetson CL; Reid TW
    Arch Ophthalmol; 2004 Nov; 122(11):1722-3. PubMed ID: 15534142
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
    Sahu SK; Murthy SI; Sangwan VS; Thomas R
    Cornea; 2006 Oct; 25(9):1130; author reply 1130-1. PubMed ID: 17133074
    [No Abstract]   [Full Text] [Related]  

  • 15. CoQ10-containing eye drops prevent UVB-induced cornea cell damage and increase cornea wound healing by preserving mitochondrial function.
    Mencucci R; Favuzza E; Boccalini C; Lapucci A; Felici R; Resta F; Chiarugi A; Cavone L
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7266-71. PubMed ID: 25301877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.
    Nishida T; Chikama T; Morishige N; Yanai R; Yamada N; Saito J
    Jpn J Ophthalmol; 2007; 51(6):442-7. PubMed ID: 18158595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions.
    Nishida T; Inui M; Nomizu M
    Prog Retin Eye Res; 2015 Jul; 47():38-63. PubMed ID: 25645519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal epithelial wound healing promoted by verbascoside-based liposomal eyedrops.
    Ambrosone L; Guerra G; Cinelli M; Filippelli M; Mosca M; Vizzarri F; Giorgio D; Costagliola C
    Biomed Res Int; 2014; 2014():471642. PubMed ID: 25165705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4.
    Dunn SP; Heidemann DG; Chow CY; Crockford D; Turjman N; Angel J; Allan CB; Sosne G
    Arch Ophthalmol; 2010 May; 128(5):636-8. PubMed ID: 20457990
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel matrix ReGeneraTing Agent promotes rapid corneal wound healing.
    Hughes L; Lockington D; Mantry S; Ramaesh K
    Clin Exp Ophthalmol; 2015; 43(4):391-2. PubMed ID: 25363832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.